Volume 40, Issue 9 pp. 829-832
Case Report

Diffuse dermal angiomatosis associated with calciphylaxis in a patient with end-stage renal disease

Katherine T. Steele

Katherine T. Steele

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Search for more papers by this author
Brendan J. Sullivan

Brendan J. Sullivan

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Search for more papers by this author
Karolyn A. Wanat

Karolyn A. Wanat

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Search for more papers by this author
Misha Rosenbach

Misha Rosenbach

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Search for more papers by this author
Rosalie Elenitsas

Corresponding Author

Rosalie Elenitsas

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Rosalie Elenitsas, MD,

Department of Dermatology, University of Pennsylvania, 3600 Spruce Street, Philadelphia, PA 19104, USA

Tel: +215 662 2737

Fax: +215 662 7884

e-mail: [email protected]

Search for more papers by this author
First published: 29 May 2013
Citations: 20

Abstract

Diffuse dermal angiomatosis (DDA) represents a benign, acquired, reactive proliferation of vessels. DDA is clinically characterized by painful livedoid plaques with central ulceration, and the histopathologic hallmark is diffuse endothelial cell hyperplasia in the dermis. DDA has been rarely reported in association with calciphylaxis, a condition characterized by calcification of arterial walls with accompanying thrombosis and cutaneous necrosis. We present a case of a 72-year-old man with end-stage renal disease on peritoneal dialysis who presented with painful lesions on his legs, and was found to have DDA in the setting of calciphylaxis. The possible pathogenesis linking DDA and calciphylaxis is discussed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.